Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Instituto de Salud Carlos III | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Dyspnea is a symptom that is growing in incidence, as respiratory and heart diseases are becoming more frequent. Patients suffering from dyspnea have a significant disabling due to chronic refractory dyspnea and crisis of irruptive dyspnea. Although there are several tools that may produce an improvement of symptom intensity, they are underused.
We sought to investigate whether if teaching interventions specifically addressed to medical staff improve the well-being of dyspneic patients. The MAIN GOAL of this study is to evaluate the effect of two talks (conveyed to doctors and nurses of Cardiology and Respiratory Medicine Departments) on the patient-perceived dyspnea. The contents of these talks will be prepared and supervised by Palliative Care specialists.
This is a four-staged study that includes a first observational phase (prevalence study of dyspnea) followed by intervention and a third phase that will determine the effect of this teaching intervention. The fourth phase consists in the elaboration of specific protocols for management of dyspnea.
A pharmacovigilance study of opioids will also take place.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients admitted before talks | Other | Patients admitted to Cardiology or Respiratory Medicine Departments before the interventional teaching talks. |
|
| Patients admitted after talks | Other | Patients admitted to Cardiology or Respiratory Medicine Departments after the interventional teaching talks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Teaching talks | Behavioral | Two teaching talks specifically addressed to medical staff which concerns the adequate treatment and needs of dyspneic patients, including pharmacological and non-pharmacological treatment. |
| Measure | Description | Time Frame |
|---|---|---|
| Decrease the number of patients with advanced heart or chronic respiratory diseases who present chronic refractory dyspnea or irruptive dyspnea and do not receive adequate treatment. | Decrease the number of patients admitted to Cardiology or Respiratory Medicine departments who present chronic respiratory dyspnea or irruptive dyspnea. | One month |
| Measure | Description | Time Frame |
|---|---|---|
| Detect the prevalence of dyspnea in patients admitted to our hospital. | Number of patients. | One month |
| Describe the therapeutic tools (pharmacological and no pharmacological) employed for symptomatic treatment of dyspnea. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Juan Manuel Nuñez Olarte, M.D. | Contact | :+34 915868122 | jnunezo@salud.madrid.org | |
| Manuel Martínez-Sellés | Contact | +34 915868286 | mmselles@secardiologia.es |
| Name | Affiliation | Role |
|---|---|---|
| Juan Manuel Nuñez Olarte, M.D. | Hospital General Universitario Gregorio Marañon | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Gregorio Marañon University Hospital | Recruiting | Madrid | Madrid | 28007 | Spain |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 12570914 | Background | Badia X, Muriel C, Gracia A, Nunez-Olarte JM, Perulero N, Galvez R, Carulla J, Cleeland CS; Grupo Vesbpi. [Validation of the Spanish version of the Brief Pain Inventory in patients with oncological pain]. Med Clin (Barc). 2003 Jan 25;120(2):52-9. doi: 10.1016/s0025-7753(03)73601-x. Spanish. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D004417 | Dyspnea |
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D012818 | Signs and Symptoms, Respiratory |
| D012816 | Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Frequency of methods usage for dyspnea relief.
| One month |
| Evaluate the impact on dyspnea intensity associated with an implementation of educational talks addressed to medical staff in the management of dyspnea. | Numerical Rating Scale score. | One year |
| Number of patients that continue chronic treatment with opioids for chronic refractory dyspnea and irruptive dyspnea. | Number of patients that receive opioid treatment at three months of inclusion | Three months |
| Determine the intensity and functional impact of dyspnea in patients admitted to our hospital. | Dyspnea intensity by Numerical Rating Scale score | One month |
| Determine the efficacy derived from a chronic treatment with opioids for chronic refractory dyspnea and irruptive dyspnea. | Dyspnea intensity by Numerical Rating Scale score | Three months |
| Determine the number of patients that present side effects derived from a chronic opioid treatment that require lowering dose or stopping treatment. | Number of patients that present side effects | Three months |
| Determine whether a specific educational talk would be affordable for dyspnea management | Costs in euros invested in medical staff training | One month |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |